13F COMBINATION REPORT
DC Funds, LP
Quarter ended Q1 2023 · Filed February 14, 2023 · Accession 0001398344-23-003141
Total Value
$3.7M
Positions
3
Other Managers
0
Confidential Omitted
No
Holdings (3)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | VACCITECH PLC | BRNS | 642,204 | $1.5M | 40.86% |
| 2 | WEREWOLF THERAPEUTICS INC | HOWL | 589,102 | $1.2M | 32.70% |
| 3 | TSCAN THERAPEUTICS INC | TCRX | 630,000 | $976,500 | 26.44% |